Sage Journals: Discover world-class research

Free access

Research article

First published 2021-11-05

Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Jun Yamamura, Yukiko Miyamura, Shunji Kamigaki [...]

Breast Disease

Open access

Research article

First published 2026

The impact of HER2 low positivity in hormone receptor-positive,HER2-negative breast cancer treated with neoadjuvant chemotherapy

Mustafa Ersoy

Cancer Biomarkers

Retricted access

Research article

First published 2024-12

Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive,HER2-Negative Metastatic/Recurrent Breast Cancer

Makiko Go, Michio Kimura, Shiori Yamada [...]

Journal of Pharmacy Practice

Open access

Review article

First published 2018

CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Adriana Matutino, Carla Amaro, Sunil Verma

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2021

Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case

Noman Ahmed Jang Khan, Mahmoud Abdallah, Maria Tria Tirona

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2021

Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Lee S. Schwartzberg, Lesli A. Kiedrowski

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025-12

Effectiveness of combined targeted and hormonal therapies for post-menopausal women with hormone receptor-positive and HER2-negative advanced breast cancer: A systematic review and meta-analysis of RCTs

Vitalis Okwor, Chika Juliet Okwor, Maryjane Ukwuoma [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors

Emma Zattarin, Luigi Mariani, Alice Menichetti [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Physician treatment decisions for hormone receptor-positive,HER2-negative early breast cancer in young patients: a Latin American survey

Dana Narvaez, Federico Waisberg, Cynthia Villarreal-Garza [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive,HER2-Negative Early Breast Cancers. A Systematic Review of the Literature

Mehwish Mooghal, Muhammad Ali Akbar Khan, Mirza Rameez Samar [...]

Breast Cancer: Basic and Clinical Research

Search results